OCUL Ocular Therapeutix, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 3, 2026
$6,96
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$6,2352-Wochen-Tief
$16,4452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.53B
P/E (TTM)
-5.0
EPS (TTM)
$-1.40
Umsatz (TTM)
$52M
Ihre Abzeichen
52W-Spanne
$6–$16
Analystenbewertung
BUY
Kursziel
$27
P/E
-5.0
ROE
-73.0%
Nettogewinnmarge
-579.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
OCUL Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$6.96
Marktkapitalisierung (MRQ)
$1.53B
P/E (TTM)
-5.0
EPS (TTM)
$-1.40
Umsatz (TTM)
$52M
ROE (TTM)
-73.0%
52W-Spanne
$6–$16
OCUL Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$52M2016-12-31 → 2025-12-31
EPS$-1.422019-12-31 → 2025-12-31
Freier Cashflow$-217M2016-12-31 → 2025-12-31
Nettogewinnmarge-579.1%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | OCUL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -5.05-Jahres-Durchschnitt ≈-6.0 | ≈-6.0 | · | · | |
| P/S (TTM) | 29.45-Jahres-Durchschnitt ≈19.4 | ≈19.4 | 13.5 | Überbewertet | |
| K/B (MRQ) | 2.95-Jahres-Durchschnitt ≈5.2 | ≈5.2 | 4.0 | Überbewertet | |
| Kurs / FCF (TTM) | -6.05-Jahres-Durchschnitt ≈-8.0 | ≈-8.0 | · | · | |
| Kurs / Cashflow (TTM) | -6.45-Jahres-Durchschnitt ≈-8.4 | ≈-8.4 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 2.35-Jahres-Durchschnitt ≈5.2 | ≈5.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | OCUL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -603.0%5-Jahres-Durchschnitt ≈-252.5% | ≈-252.5% | -126.9% | Schwach | |
| EBITDA-Marge (TTM) | -592.6%5-Jahres-Durchschnitt ≈-246.7% | ≈-246.7% | -119.9% | Schwach | |
| Nettogewinnmarge (TTM) | -579.1%5-Jahres-Durchschnitt ≈-221.3% | ≈-221.3% | -99.3% | Schwach | |
| ROA (TTM) | -53.7%5-Jahres-Durchschnitt ≈-35.9% | ≈-35.9% | -27.5% | Schwach | |
| ROE (TTM) | -73.0%5-Jahres-Durchschnitt ≈-91.6% | ≈-91.6% | -26.1% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | OCUL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 13.15-Jahres-Durchschnitt ≈8.8 | ≈8.8 | 11.8 | Im Einklang | |
| Quick Ratio | 15.15-Jahres-Durchschnitt ≈8.5 | ≈8.5 | 9.9 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | OCUL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -18.5%5-Jahres-Durchschnitt ≈34.5% | ≈34.5% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 0.29%5-Jahres-Durchschnitt ≈21.2% | ≈21.2% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 24.4% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | OCUL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.2 | ≈0.2 | 0.2 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 2.05-Jahres-Durchschnitt ≈2.6 | ≈2.6 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 1.65-Jahres-Durchschnitt ≈2.3 | ≈2.3 | 4.5 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$159.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-5.9%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 3, 2026 | $-0.35 | $-0.40 | 13.2% |
| 31. März 2026 | Mai 11, 2026 | $-0.40 | $-0.32 | -25.6% |
| 31. Dezember 2025 | $-0.29 | $-0.33 | 12.7% | |
| 30. September 2025 | $-0.38 | $-0.37 | -1.6% | |
| 30. Juni 2025 | $-0.39 | $-0.36 | -7.8% | |
| 31. März 2025 | $-0.38 | $-0.30 | -26.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $52M | $64M | $58M | $51M | $44M | $17M | $4M | $2M | $2M | $2M | $2M | $772.0K | |
| Cost of Revenue | $7M | $6M | $5M | $5M | $4M | $2M | $2M | $465.0K | $457.0K | $443.0K | $319.0K | $91.0K | |
| R&D Expense | $197M | $128M | $61M | $53M | $50M | $29M | $41M | $37M | $31M | $27M | $27M | $19M | |
| SG&A Expense | $64M | $61M | $34M | $32M | $32M | $23M | $22M | $19M | $16M | $11M | $9M | $7M | |
| Operating Expenses | $322M | $236M | $141M | $130M | $122M | $80M | $90M | $61M | $64M | $45M | $40M | $28M | |
| Operating Income | $-270M | $-172M | $-82M | $-79M | $-78M | $-63M | $-86M | $-59M | $-62M | $-43M | $-38M | $-27M | |
| Interest Expense | · | · | $11M | $7M | $7M | $7M | $6M | $2M | $2M | $2M | $2M | $1M | |
| Other Non-op | $4M | $-22M | $2M | $-1.0K | $1.0K | · | $-8.0K | · | $5.0K | $-1.0K | $7.0K | $-442.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-266M | $-194M | $-81M | $-71M | $-7M | $-156M | $-86M | $-60M | $-63M | $-45M | $-40M | $-29M | |
| EPS (Basic) | $-1.42 | $-1.22 | $-1.01 | $-0.92 | $-0.09 | $-2.56 | $-1.91 | · | · | · | · | · | |
| EPS (Diluted) | $-1.42 | $-1.22 | $-1.02 | $-0.97 | $-0.98 | $-2.56 | $-1.91 | · | · | · | · | · | |
| Shares (Basic) | 187,241,483 | 158,265,162 | 79,827,362 | 76,875,035 | 76,392,870 | 60,752,225 | 45,273,231 | · | · | · | · | · | |
| Shares (Diluted) | 187,241,483 | 158,265,162 | 85,596,594 | 82,644,267 | 82,162,102 | 60,752,225 | 45,273,231 | · | · | · | · | · | |
| EBITDA | $-266M | $-168M | $-79M | $-77M | $-76M | $-60M | $-83M | $-57M | $-60M | $-42M | $-37M | $-27M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $737M | $392M | $196M | $102M | $164M | $228M | $54M | $54M | $42M | $33M | $31M | $37M | |
| Receivables | $31M | $32M | $26M | $21M | $21M | $12M | $3M | $201.0K | $226.0K | $250.0K | $193.0K | $329.0K | |
| Inventory | $4M | $3M | $2M | $2M | $1M | $1M | $954.0K | $217.0K | $122.0K | $113.0K | $134.0K | $133.0K | |
| Prepaid Expense | $11M | $13M | $8M | $4M | $5M | $5M | $2M | $2M | $1M | $1M | $2M | $893.0K | |
| Current Assets | $782M | $441M | $232M | $130M | $191M | $246M | $60M | $56M | $43M | $70M | $107M | $76M | |
| PP&E (Net) | $20M | $9M | $12M | $10M | $7M | $8M | $10M | $10M | $10M | $3M | $3M | $2M | |
| PP&E (Gross) | $47M | $33M | $32M | $27M | $22M | $21M | $20M | $18M | $16M | $7M | $6M | $4M | |
| Accum. Depreciation | $28M | $24M | $20M | $17M | $15M | $13M | $10M | $8M | $5M | $4M | $3M | $2M | |
| Total Assets | $808M | $458M | $252M | $149M | $205M | $262M | $79M | $73M | $55M | $75M | $110M | $78M | |
| Accounts Payable | $4M | $4M | $4M | $5M | $5M | $3M | $3M | $3M | $4M | $2M | $2M | $1M | |
| Accrued Liabilities | $44M | $35M | $29M | $24M | $20M | $14M | $8M | $6M | $4M | $5M | $3M | $3M | |
| Short-term Debt | · | · | · | · | · | $8M | · | · | $6M | $2M | · | $1M | |
| Current Liabilities | $51M | $41M | $35M | $31M | $26M | $27M | $12M | $9M | $13M | $8M | $5M | $6M | |
| Capital Leases | $3M | $5M | $7M | $9M | $6M | $8M | $9M | · | · | · | · | · | |
| Other Non-current Liabilities | $887.0K | $141.0K | $108.0K | $93.0K | · | · | · | $3M | · | · | · | · | |
| Total Liabilities | $154M | $143M | $161M | $114M | $117M | $186M | $82M | $37M | $29M | $23M | $21M | $19M | |
| Total Debt | · | · | · | · | · | $8M | · | · | $6M | $2M | · | $1M | |
| Common Stock | $22.0K | $16.0K | $12.0K | $8.0K | $8.0K | $8.0K | $5.0K | $4.0K | $3.0K | $3.0K | $2.0K | $2.0K | |
| Retained Earnings | $-1.16B | $-891M | $-698M | $-617M | $-546M | $-539M | $-384M | $-297M | $-237M | $-174M | $-129M | $-89M | |
| AOCI | · | · | · | · | · | · | · | · | · | $-5.0K | $-68.0K | · | |
| Stockholders' Equity | $654M | $315M | $91M | $35M | $88M | $76M | $-4M | $36M | $26M | $52M | $90M | $59M | |
| Liabilities + Equity | $808M | $458M | $252M | $149M | $205M | $262M | $79M | $73M | $55M | $75M | $110M | $78M | |
| Shares Outstanding | 215,927,600 | 157,749,490 | 114,963,193 | 77,201,819 | 76,731,940 | 75,996,732 | 50,333,559 | 41,518,091 | 29,658,202 | 25,024,100 | 24,750,281 | 21,333,507 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $881.0K | $754.0K | $547.0K | |
| Stock-based Comp | $43M | $33M | $18M | $17M | $15M | $8M | $9M | $7M | $7M | $6M | $5M | $3M | |
| Restructuring | · | · | · | · | · | · | $3M | · | $3M | · | · | · | |
| Other Non-cash | $14M | $22M | $-10M | $-8M | $-76M | $92M | $-2M | $982.0K | $4M | $4M | $611.0K | $5M | |
| Operating Cash Flow | $-205M | $-135M | $-70M | $-60M | $-66M | $-54M | $-78M | $-49M | $-50M | $-34M | $-34M | $-20M | |
| CapEx | $12M | $1M | $6M | $4M | $1M | $841.0K | $2M | $2M | $8M | $2M | $2M | $1M | |
| Investing Cash Flow | $-12M | $-1M | $-6M | $-4M | $-1M | $-841.0K | $-2M | $-2M | $27M | $37M | $-39M | · | |
| Debt Issued | · | · | $82M | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | $117M | · | · | $225M | $38M | $62M | $29M | $627.0K | $66M | $70M | |
| Net Stock Activity | · | · | $117M | · | · | $225M | $38M | $62M | $29M | $872.0K | · | $70M | |
| Financing Cash Flow | $562M | $332M | $170M | $1M | $3M | $228M | $75M | $69M | $32M | $585.0K | $66M | · | |
| Net Change in Cash | $345M | $196M | $94M | $-62M | $-64M | $174M | $-4M | $18M | $8M | $4M | $-7M | $20M | |
| Free Cash Flow | $-217M | $-136M | $-76M | $-63M | $-67M | $-54M | $-80M | $-51M | $-59M | $-36M | $-36M | $-22M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -519.8% | -269.6% | -141.0% | -152.7% | -179.3% | -361.1% | -2029.9% | -2970.8% | -3220.1% | -2296.0% | -2182.7% | -3509.6% | |
| Net Margin | -511.9% | -303.7% | -138.1% | -137.9% | -15.1% | -894.3% | -2043.3% | -3014.0% | -3296.2% | -2369.0% | -2271.3% | -3710.9% | |
| EBITDA Margin | -511.4% | -263.6% | -135.9% | -148.7% | -173.7% | -345.2% | -1970.0% | -2855.9% | -3135.6% | -2249.3% | -2139.6% | -3438.7% | |
| ROA | -42.0% | -54.5% | -40.2% | -40.1% | -2.8% | -91.4% | -113.8% | -93.4% | -97.2% | -48.3% | -42.2% | -58.9% | |
| ROE | -55.4% | -58.0% | -163.1% | -174.1% | -7.5% | -432.5% | -2251.9% | -147.4% | -162.2% | -63.1% | -53.6% | 7383.5% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.4 | 10.7 | 6.7 | 4.1 | 7.3 | 9.2 | 5.0 | 6.1 | 3.2 | 8.4 | 19.9 | 13.0 | |
| Quick Ratio | 15.1 | 10.3 | 6.4 | 3.9 | 7.0 | 9.0 | 4.7 | 5.9 | 3.1 | 4.0 | 5.8 | 6.4 | |
| Debt / Equity | · | · | · | · | · | 0.1 | · | · | 0.2 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | -7.3 | -11.2 | -11.7 | -9.3 | -14.1 | -34.0 | -32.7 | -25.8 | -22.2 | -24.2 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 2.0 | 2.1 | 2.5 | 2.8 | 3.6 | 1.9 | 4.0 | · | 3.9 | 3.6 | 2.4 | 1.4 | |
| Receivables Turnover | 1.6 | 2.2 | 2.5 | 2.4 | 2.6 | 2.4 | 3.1 | 9.3 | 8.1 | 8.5 | 6.7 | 2.7 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.03 | $2.00 | $0.79 | $0.46 | $1.15 | $1.00 | $-0.07 | $0.86 | $0.88 | $2.08 | $3.62 | $2.75 | |
| Revenue / Share | $0.28 | $0.40 | $0.68 | $0.62 | $0.53 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-1.09 | $-0.85 | $-0.82 | $-0.72 | $-0.80 | · | · | · | · | · | · | · | |
| Cash / Share | $3.41 | $2.49 | $1.70 | $1.33 | $2.14 | $3.00 | $1.08 | $1.30 | $1.40 | $1.32 | $1.24 | $1.75 | |
| EPS (TTM) | $-1.42 | $-1.22 | $-1.02 | $-0.97 | $-0.98 | $-2.56 | $-1.91 | $-1.57 | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -18.5% | 9.0% | 13.5% | 18.3% | 150.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.29% | 13.6% | 49.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 24.4% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $52M | $64M | $58M | $51M | $44M | $17M | $4M | $2M | $2M | $2M | $2M | $772.0K | |
| Net Income TTM | $-266M | $-194M | $-81M | $-71M | $-7M | $-156M | $-86M | $-60M | $-63M | $-45M | $-40M | $-29M | |
| Market Cap | $2.62B | $1.35B | $513M | $217M | $535M | $1.57B | $199M | $165M | $132M | $209M | $232M | $502M | |
| Enterprise Value | · | · | · | · | · | $1.35B | · | · | $96M | $178M | · | $466M | |
| P/E | -8.5 | -7.0 | -4.4 | -2.9 | -7.1 | -8.1 | -2.1 | -2.5 | · | · | · | · | |
| P/S | 50.5 | 21.1 | 8.8 | 4.2 | 12.3 | 90.4 | 47.0 | 83.0 | 68.6 | 111.0 | 132.5 | 650.0 | |
| P/B | 4.0 | 4.3 | 5.6 | 6.1 | 6.1 | 20.7 | -54.8 | 4.6 | 5.0 | 4.0 | 2.6 | 8.5 | |
| P / Tangible Book | 4.0 | 4.3 | 5.6 | 6.1 | 6.1 | 20.7 | · | · | · | · | · | · | |
| P / Cash Flow | -12.8 | -10.0 | -7.3 | -3.6 | -8.2 | -29.4 | -2.6 | -3.4 | -2.6 | -6.2 | -6.9 | -24.5 | |
| P / FCF | -12.1 | -9.9 | -6.7 | -3.4 | -8.0 | -28.9 | -2.5 | -3.2 | -2.2 | -5.8 | -6.5 | -23.1 | |
| EV / EBITDA | · | · | · | · | · | -22.5 | · | · | -1.6 | -4.2 | · | -17.5 | |
| EV / FCF | · | · | · | · | · | -24.9 | · | · | -1.6 | -5.0 | · | -21.4 | |
| EV / Revenue | · | · | · | · | · | 77.8 | · | · | 49.9 | 94.4 | · | 603.3 | |
| Earnings Yield | -11.7% | -14.3% | -22.9% | -34.5% | -14.1% | -12.4% | -48.4% | -39.5% | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13M | $11M | $13M | $15M | $13M | $11M | $17M | $15M | $16M | $15M | $15M | $15M | $15M | $13M | $14M | $12M | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| R&D Expense | $54M | $66M | $51M | $52M | $51M | $43M | $41M | $37M | $29M | $21M | $16M | $15M | $15M | $15M | $14M | $14M | |
| SG&A Expense | $22M | $20M | $18M | $16M | $14M | $16M | $15M | $12M | $20M | $14M | $8M | $9M | $8M | $9M | $8M | $9M | |
| Operating Expenses | $96M | $104M | $83M | $83M | $81M | $75M | $68M | $61M | $60M | $46M | $35M | $34M | $36M | $36M | $33M | $34M | |
| Operating Income | $-82M | $-93M | $-70M | $-69M | $-68M | $-64M | $-51M | $-46M | $-44M | $-32M | $-20M | $-19M | $-21M | $-23M | $-19M | $-22M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $3M | $2M | $2M | · | $2M | |
| Other Non-op | $3M | $5M | $5M | $-720.0K | $-173.0K | $-136.0K | $2M | $10M | $-187.0K | $-33M | $2M | $0 | $0 | $-1.0K | $0 | $1.0K | |
| Net Income | $-79M | $-89M | $-65M | $-69M | $-68M | $-64M | $-48M | $-36M | $-44M | $-65M | $-29M | $-516.0K | $-21M | $-30M | $-16M | $-24M | |
| EPS (Basic) | $-0.35 | $-0.40 | $-0.27 | $-0.38 | $-0.39 | $-0.38 | $-0.25 | $-0.22 | $-0.26 | $-0.49 | $-0.35 | $-0.01 | $-0.26 | $-0.39 | $-0.21 | $-0.31 | |
| EPS (Diluted) | $-0.35 | $-0.40 | $-0.27 | $-0.38 | $-0.39 | $-0.38 | $-0.25 | $-0.22 | $-0.26 | $-0.49 | $-0.12 | $-0.25 | $-0.26 | $-0.39 | $-0.19 | $-0.31 | |
| Shares (Basic) | 224,952,428 | 224,099,410 | · | 183,919,808 | 172,594,662 | 169,396,989 | · | 166,992,735 | 165,824,778 | 132,021,945 | · | 79,373,272 | 78,047,705 | 77,386,287 | · | 76,975,839 | |
| Shares (Diluted) | 224,952,428 | 224,099,410 | · | 183,919,808 | 172,594,662 | 169,396,989 | · | 166,992,735 | 165,824,778 | 132,021,945 | · | 85,142,504 | 78,047,705 | 77,386,287 | · | 76,975,839 | |
| EBITDA | $-82M | $-92M | · | $-69M | $-68M | $-63M | · | $-46M | $-44M | $-31M | · | $-19M | $-21M | $-22M | · | $-22M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $599M | $667M | $737M | $345M | $391M | $350M | $392M | $427M | $460M | $483M | $196M | $111M | $67M | $79M | $102M | $121M | |
| Receivables | $30M | $24M | $31M | $31M | $30M | $25M | $32M | $30M | $30M | $27M | · | $24M | $27M | $21M | · | $20M | |
| Inventory | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | · | $2M | $2M | $2M | · | $2M | |
| Prepaid Expense | $12M | $11M | $11M | $8M | $9M | $10M | $13M | $13M | $6M | $8M | · | $5M | $5M | $5M | · | $3M | |
| Current Assets | $644M | $706M | $782M | $387M | $433M | $388M | $441M | $473M | $499M | $520M | · | $141M | $101M | $107M | · | $146M | |
| PP&E (Net) | $19M | $18M | $20M | $17M | $10M | $11M | $9M | $10M | $11M | $11M | · | $12M | $13M | $12M | · | $7M | |
| PP&E (Gross) | · | · | $47M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $28M | · | · | · | $24M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $671M | $733M | $808M | $411M | $451M | $406M | $458M | $490M | $517M | $539M | · | $162M | $123M | $129M | · | $159M | |
| Accounts Payable | $7M | $8M | $4M | $6M | $6M | $5M | $4M | $4M | $4M | $6M | · | $4M | $4M | $5M | · | $5M | |
| Accrued Liabilities | $39M | $36M | $44M | $40M | $34M | $31M | $35M | $30M | $24M | $16M | · | $29M | $25M | $22M | · | $22M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | · | |
| Current Liabilities | $49M | $48M | $51M | $49M | $43M | $38M | $41M | $36M | $30M | $24M | · | $35M | $32M | $30M | · | $29M | |
| Capital Leases | $3M | $4M | $3M | $4M | $4M | $5M | $5M | $6M | $6M | $6M | · | $7M | $8M | $8M | · | $5M | |
| Other Non-current Liabilities | $931.0K | $909.0K | $887.0K | $151.0K | $148.0K | $144.0K | $141.0K | $117.0K | $114.0K | $111.0K | · | $106.0K | $104.0K | $100.0K | · | · | |
| Total Liabilities | $151M | $151M | $154M | $153M | $145M | $140M | $143M | $138M | $139M | $131M | · | $155M | $119M | $119M | · | $112M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | · | |
| Common Stock | $22.0K | $22.0K | $22.0K | $18.0K | $17.0K | $16.0K | $16.0K | $16.0K | $16.0K | $15.0K | · | $8.0K | $8.0K | $8.0K | · | $8.0K | |
| Retained Earnings | $-1.32B | $-1.25B | $-1.16B | $-1.09B | $-1.02B | $-955M | $-891M | $-843M | $-806M | $-762M | · | $-668M | $-668M | $-647M | · | $-601M | |
| Stockholders' Equity | $520M | $582M | $654M | $258M | $306M | $266M | $315M | $352M | $378M | $408M | $91M | $8M | $3M | $10M | $35M | $46M | |
| Liabilities + Equity | $671M | $733M | $808M | $411M | $451M | $406M | $458M | $490M | $517M | $539M | · | $162M | $123M | $129M | · | $159M | |
| Shares Outstanding | 219,589,303 | 218,896,915 | 215,927,600 | 174,949,558 | 172,925,389 | 159,262,024 | 157,749,490 | 156,654,938 | 155,624,363 | 154,704,086 | · | 79,412,114 | 79,233,804 | 77,516,638 | · | 77,010,385 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $1M | $1M | $1M | $1M | $981.0K | $951.0K | $959.0K | $956.0K | $920.0K | $958.0K | $890.0K | $652.0K | $483.0K | $491.0K | $509.0K | |
| Stock-based Comp | $15M | $16M | $11M | $12M | $10M | $10M | $7M | $7M | $11M | $8M | $4M | $5M | $4M | $5M | $4M | $4M | |
| Restructuring | · | · | · | · | · | · | · | · | $2M | · | · | · | · | · | · | · | |
| Other Non-cash | · | $6M | · | · | · | $8M | · | · | · | $22M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $-67M | $-66M | $-54M | $-51M | $-55M | $-45M | $-39M | $-37M | $-25M | $-34M | $-22M | $-8M | $-20M | $-20M | $-17M | $-13M | |
| CapEx | $3M | $5M | $3M | $6M | $1M | $2M | $202.0K | $89.0K | $742.0K | $255.0K | $459.0K | $259.0K | $2M | $3M | $2M | $794.0K | |
| Investing Cash Flow | $-3M | $-5M | $-3M | $-6M | $-1M | $-2M | $-202.0K | $-89.0K | $-742.0K | $-255.0K | $-459.0K | $-259.0K | $-2M | $-3M | $-2M | $-794.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $316M | · | $708.0K | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $316M | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $294.0K | $449M | $10M | $98M | $4M | $5M | $4M | $2M | $321M | $108M | $52M | $10M | $78.0K | $458.0K | $374.0K | |
| Net Change in Cash | $-68M | $-70M | $392M | $-46M | $41M | $-42M | $-35M | $-32M | $-23M | $287M | $85M | $44M | $-12M | $-23M | $-19M | $-14M | |
| Free Cash Flow | · | $-71M | · | · | · | $-47M | · | · | · | $-34M | · | · | · | $-23M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -609.3% | -865.5% | · | -472.3% | -502.6% | -597.5% | · | -298.2% | -265.1% | -214.0% | · | -127.4% | -135.5% | -168.6% | · | -180.1% | |
| Net Margin | -584.5% | -821.6% | · | -477.3% | -503.9% | -598.7% | · | -236.6% | -266.3% | -438.9% | · | -3.4% | -136.2% | -226.7% | · | -202.2% | |
| EBITDA Margin | -609.3% | -853.6% | · | -472.3% | -502.6% | -588.3% | · | -298.2% | -265.1% | -207.8% | · | -127.4% | -135.5% | -165.0% | · | -180.1% | |
| ROA | -14.0% | -15.6% | · | -15.4% | -14.0% | -13.6% | · | -11.2% | -13.7% | -19.4% | · | -0.32% | -14.0% | -19.2% | · | -12.9% | |
| ROE | -19.1% | -20.9% | · | -22.8% | -19.8% | -19.0% | · | -20.3% | -23.0% | -31.1% | · | -1.9% | -60.0% | -67.8% | · | -36.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.1 | 14.8 | · | 7.9 | 10.1 | 10.2 | · | 13.0 | 16.6 | 21.4 | · | 4.0 | 3.1 | 3.6 | · | 5.0 | |
| Quick Ratio | 12.8 | 14.5 | · | 7.6 | 9.8 | 9.9 | · | 12.6 | 16.3 | 21.0 | · | 3.8 | 2.9 | 3.4 | · | 4.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | 0.7 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -7.8 | · | -5.6 | -10.3 | -12.8 | · | -12.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.6 | 0.4 | · | 0.6 | 0.7 | 0.4 | · | 0.7 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.7 | · | 0.8 | |
| Receivables Turnover | 0.4 | 0.4 | · | 0.5 | 0.4 | 0.4 | · | 0.6 | 0.6 | 0.6 | · | 0.7 | 0.6 | 0.6 | · | 0.6 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.37 | $2.66 | · | $1.48 | $1.77 | $1.67 | · | $2.25 | $2.43 | $2.64 | · | $0.10 | $0.04 | $0.13 | · | $0.60 | |
| Revenue / Share | $0.06 | $0.05 | · | $0.08 | $0.08 | $0.06 | · | $0.09 | $0.10 | $0.11 | · | $0.18 | $0.19 | $0.17 | · | $0.16 | |
| Cash Flow / Share | · | $-0.29 | · | · | · | $-0.26 | · | · | · | $-0.26 | · | · | · | $-0.26 | · | · | |
| Cash / Share | $2.73 | $3.05 | · | $1.97 | $2.26 | $2.20 | · | $2.73 | $2.95 | $3.12 | · | $1.39 | $0.84 | $1.02 | · | $1.57 | |
| EPS (TTM) | $-1.40 | $-1.44 | · | $-1.40 | $-1.24 | $-1.11 | · | $-1.09 | $-1.12 | $-1.12 | · | $-1.09 | $-1.15 | $-1.14 | · | $-1.04 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $52M | $52M | · | $56M | $57M | $60M | · | $61M | $61M | $60M | · | $58M | $55M | $52M | · | $50M | |
| Net Income TTM | $-301M | $-290M | · | $-250M | $-217M | $-193M | · | $-174M | $-138M | $-115M | · | $-67M | $-91M | $-89M | · | $-59M | |
| Market Cap | $2.16B | $1.85B | · | $2.05B | $1.60B | $1.17B | · | $1.36B | $1.06B | $1.41B | · | $249M | $409M | $409M | · | $320M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | $344M | · | · | · | |
| P/E | -7.0 | -5.9 | · | -8.3 | -7.5 | -6.6 | · | -8.0 | -6.1 | -8.1 | · | -2.9 | -4.5 | -4.6 | · | -4.0 | |
| P/S | 41.4 | 35.6 | · | 36.7 | 28.3 | 19.6 | · | 22.2 | 17.4 | 23.5 | · | 4.3 | 7.5 | 7.9 | · | 6.4 | |
| P/B | 4.1 | 3.2 | · | 7.9 | 5.2 | 4.4 | · | 3.9 | 2.8 | 3.5 | · | 31.8 | 132.4 | 42.1 | · | 6.9 | |
| P / Tangible Book | 4.1 | 3.2 | · | 7.9 | 5.2 | 4.4 | · | 3.9 | 2.8 | 3.5 | · | 31.8 | 132.4 | 42.1 | · | 6.9 | |
| P / Cash Flow | · | -28.1 | · | · | · | -26.1 | · | · | · | -41.5 | · | · | · | -20.5 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | 6.3 | · | · | · | |
| Earnings Yield | -14.3% | -17.0% | · | -12.0% | -13.4% | -15.1% | · | -12.5% | -16.4% | -12.3% | · | -34.7% | -22.3% | -21.6% | · | -25.1% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $52M | $64M | $58M | $51M | $44M |
| Betriebsgewinnmarge % | -519.8% | -269.6% | -141.0% | -152.7% | -179.3% |
| Nettoergebnis | $-266M | $-194M | $-81M | $-71M | $-7M |
| Verwässerte EPS | $-1.42 | $-1.22 | $-1.02 | $-0.97 | $-0.98 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 15.4 | 10.7 | 6.7 | 4.1 | 7.3 |
| Quick Ratio | 15.1 | 10.3 | 6.4 | 3.9 | 7.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-217M | $-136M | $-76M | $-63M | $-67M |
Institutionelle Eigentümer (13F) 286 Einreicher · $2.1B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
286
Gehaltener Wert
$2.1B
Neue Positionen
34
Geschlossene Positionen
40
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 34 (-51 vs. Vorquartal) | 40 (-8 vs. Vorquartal) | 104 (-8 vs. Vorquartal) | 83 (+24 vs. Vorquartal) | -3.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $322.528.499 | 32.844.043 | 15,37% | Aktien |
| Deep Track Capital, LP | $193.319.289 | 19.686.282 | 9,21% | Aktien |
| BlackRock, Inc. | $190.277.772 | 19.376.555 | 9,07% | Aktien |
| VANGUARD GROUP INC | $140.522.844 | 11.575.193 | 6,70% | Aktien |
| Avoro Capital Advisors LLC | $123.142.800 | 12.540.000 | 5,87% | Aktien |
| Summer Road LLC | $119.885.466 | 12.208.296 | 5,71% | Aktien |
| Venrock Adviser, LLC | $101.606.813 | 10.346.926 | 4,84% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $86.736.083 | 8.832.595 | 4,13% | Aktien |
| Logos Global Management LP | $52.046.000 | 5.300.000 | 2,48% | Aktien |
| STATE STREET CORP | $51.390.829 | 5.233.282 | 2,45% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $49.315.115 | 5.021.092 | 2,35% | Aktien |
| Point72 Asset Management, L.P. | $32.329.335 | 3.292.193 | 1,54% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $27.334.041 | 2.783.367 | 1,30% | Aktien |
| Balyasny Asset Management L.P. | $22.298.343 | 2.270.707 | 1,06% | Aktien |
| Octagon Capital Advisors LP | $20.376.500 | 2.075.000 | 0,97% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19.376.137 | 1.973.130 | 0,92% | Aktien |
| NORTHERN TRUST CORP | $17.670.364 | 1.799.426 | 0,84% | Aktien |
| GOLDMAN SACHS GROUP INC | $17.300.424 | 1.761.754 | 0,82% | Aktien |
| Nuveen, LLC | $16.667.230 | 1.697.274 | 0,79% | Aktien |
| Woodline Partners LP | $16.375.920 | 1.667.609 | 0,78% | Aktien |
| TCG Crossover Management, LLC | $16.180.925 | 1.647.752 | 0,77% | Aktien |
| UBS Group AG | $15.230.829 | 1.551.001 | 0,73% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $15.221.000 | 1.550.000 | 0,73% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $15.058.361 | 1.533.438 | 0,72% | Aktien |
| Defilade Capital Management, L.P. | $14.634.609 | 1.490.286 | 0,70% | Aktien |
| Squarepoint Ops LLC | $13.904.266 | 1.415.913 | 0,66% | Aktien |
| Invesco Ltd. | $13.201.919 | 1.344.391 | 0,63% | Aktien |
| Boxer Capital Management, LLC | $12.766.000 | 1.300.000 | 0,61% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $12.659.944 | 1.289.200 | 0,60% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $11.965.798 | 1.218.513 | 0,57% | Aktien |
| Knoll Capital Management, LLC | $11.296.928 | 1.150.400 | 0,54% | Aktien |
| Balyasny Asset Management L.P. | $9.576.464 | 975.200 | 0,46% | Kaufoption |
| RAYMOND JAMES FINANCIAL INC | $9.459.763 | 963.316 | 0,45% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $9.332.319 | 950.338 | 0,44% | Aktien |
| MORGAN STANLEY | $8.954.187 | 911.831 | 0,43% | Aktien |
| Candriam S.C.A. | $8.906.402 | 907.839 | 0,42% | Aktien |
| Empire Life Investments Inc. | $8.560.015 | 871.692 | 0,41% | Aktien |
| Cetera Investment Advisers | $7.715.885 | 785.732 | 0,37% | Aktien |
| PEREGRINE CAPITAL MANAGEMENT LLC | $7.399.321 | 753.495 | 0,35% | Aktien |
| Aptus Capital Advisors, LLC | $6.271.946 | 638.691 | 0,30% | Aktien |
| Second Line Capital, LLC | $6.271.445 | 638.640 | 0,30% | Aktien |
| Opaleye Management Inc. | $5.892.000 | 600.000 | 0,28% | Aktien |
| ALGERT GLOBAL LLC | $5.816.474 | 592.309 | 0,28% | Aktien |
| Cubist Systematic Strategies, LLC | $5.449.633 | 466.179 | 0,26% | Aktien |
| Bank of New York Mellon Corp | $5.432.780 | 553.236 | 0,26% | Aktien |
| Man Group plc | $5.337.975 | 543.582 | 0,25% | Aktien |
| Sio Capital Management, LLC | $5.297.821 | 539.493 | 0,25% | Aktien |
| ACUTA CAPITAL PARTNERS, LLC | $5.228.963 | 532.481 | 0,25% | Aktien |
| AXA Investment Managers S.A. | $5.142.209 | 439.881 | 0,25% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $5.132.551 | 522.663 | 0,24% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Summer Road LLC ×6 Einreichungen | 27. Februar 2024 | · | Erste Einreichung | Passive Anlage | SEC |
| Amarpreet Sawhney | 4. August 2014 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 37 Insider · 25 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Dugel Pravin | Executive Chairman, President and CEO | 25. August 2026 G | 744.903 | 0 | 5 | $-1.936.777 |
| Antony C. Mattessich | President and CEO | 3. Februar 2024 A | 588.701 | 0 | 0 | $0 |
| Jason Shand Robins | Chief Financial Officer | 10. Juni 2026 A | 68.097 | 0 | 0 | $0 |
| Bradford W Smith | CFO and Treasurer | 31. Januar 2017 A | · | 0 | 0 | $0 |
| Michael H. Goldstein | President, Ophthalmology & CMO | 3. Februar 2022 A | 313.335 | 0 | 0 | $0 |
| Donald Notman | Chief Operating Officer | 31. August 2026 S | 366.529 | 0 | 4 | $-216.124 |
| Patricia Kitchen | Chief Operating Officer | 17. Februar 2021 A | · | 0 | 0 | $0 |
| James Fortune | Chief Operating Officer | 31. Januar 2017 A | 112.060 | 0 | 0 | $0 |
| Sanjay Nayak | Chief Strategy Officer | 24. August 2026 S | 326.898 | 0 | 5 | $-166.408 |
| Peter Kaiser | Chief Development Officer | 24. August 2026 S | 264.378 | 0 | 5 | $-222.900 |
| Jeffrey S. Heier | Chief Scientific Officer | 24. August 2026 S | 318.326 | 0 | 5 | $-243.300 |
| Nadia Waheed | Chief Medical Officer | 3. Juni 2026 S | 300.079 | 0 | 3 | $-220.877 |
| David Wayne Robinson | Global CCO | 21. Januar 2026 A | 136.000 | 0 | 0 | $0 |
| Steve Lawrence Meyers | Chief Commercial Officer | 2. Januar 2026 A | 217.628 | 0 | 0 | $0 |
| Namrata Saroj | Chief Business Officer | 2. Januar 2026 A | 254.620 | 0 | 1 | $-277.790 |
| Todd Anderman | Chief Legal Officer | 2. Januar 2026 A | 152.468 | 0 | 1 | $-137.369 |
| Philip C. Strassburger | General Counsel | 3. Februar 2024 A | 161.493 | 0 | 0 | $0 |
| Rabia Gurses Ozden | Chief Medical Officer | 3. Februar 2024 A | 153.054 | 0 | 0 | $0 |
| Christopher G White | Chief Business Officer | 3. Februar 2024 A | 123.689 | 0 | 0 | $0 |
| Amarpreet Sawhney | Chairman of the Board | 7. Juni 2019 P | 1.056.031 | 0 | 0 | $0 |
| Kevin F. Hanley | Sr. VP Technical Operations | 2. Januar 2019 A | 20.000 | 0 | 0 | $0 |
| Daniel M Bollag | Sr. VP Reg. Affairs & Quality | 2. Januar 2019 A | 42.100 | 0 | 0 | $0 |
| Charles Andrew Hurley | Chief Commercial Officer | 31. Januar 2017 A | · | 0 | 0 | $0 |
| Jonathan H. Talamo | Chief Medical Officer | 31. Januar 2017 A | · | 0 | 0 | $0 |
| Eric Ankerud | EVP, Regulatory, Quality & Compliance | 31. Januar 2017 A | 78.651 | 0 | 0 | $0 |
| Seung Suh Hong | Direktor | 10. Juni 2026 A | 60.933 | 0 | 0 | $0 |
| Leslie J. Williams | Direktor | 10. Juni 2026 A | 65.433 | 0 | 0 | $0 |
| Charles M Warden | Direktor | 10. Juni 2026 A | 100.464 | 0 | 0 | $0 |
| Adrienne L Graves | Direktor | 10. Juni 2026 A | 64.000 | 0 | 0 | $0 |
| Richard L Lindstrom MD | Direktor | 10. Juni 2026 A | 260.933 | 1 | 0 | $461.354 |
| RAINES MERILEE | Direktor | 10. Juni 2026 A | 60.933 | 0 | 0 | $0 |
| Bruce Peacock | Direktor | 18. Juni 2021 A | 0 | 0 | 0 | $0 |
| Jaswinder Chadha | Direktor | 14. Juni 2018 A | 130.448 | 0 | 0 | $0 |
| William J Oshea | Direktor | 14. Juni 2018 A | · | 0 | 0 | $0 |
| James M Garvey | Direktor | 1. Juni 2017 A | · | 0 | 0 | $0 |
| SUMMER ROAD LLC | 10%-Eigentümer | 26. Februar 2024 P | 8.591.401 | 0 | 0 | $0 |
| Opaleye Management Inc. | 10%-Eigentümer | 2. Januar 2020 P | 4.918.500 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 31 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,26% | 1.643.349 SH | 1. Oktober 2026 | Täglich |
| PILL · Direxion Shares ETF Trust | 1,06% | 26.875 NS | 31. Juli 2026 | N-PORT |
| IHE · iShares Trust | 0,43% | 648.363 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,12% | 1.600.462 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,11% | 15.486 SH | 1. Oktober 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 182.430 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,07% | 5.249.940 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 1.184.781 SH | 19. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 49.284 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,05% | 98.364 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 655.948 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,03% | 29.285 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 83.872 SH | 1. Oktober 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2.002.729 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 31.096 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 458.715 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 71.456 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 7.396 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,01% | 4.787 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 398.601 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 24.851 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 9.322 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 50.224 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 239.486 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 45.895 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 47.187 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 6.619.445 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 17.379 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 330.350 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 8.186 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 19.197 SH | 11. September 2026 | Täglich |
OCUL Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 18 Analysten
KAUF
Median-Ziel
$28.00
+302,3%
6 33,3%
Starker Kauf
11 61,1%
Kauf
1 5,6%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
11 Analysten · 2026-09-30Mittelwert-Ziel $27.09 +289,2%
← Unter allen Zielen
Aktueller Preis $6.96
Tief$18.00
Mittelwert$27.09
Hoch$34.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | · |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| ETON | $457M | · | 104.9% | -5.8% | -18.4% | 53.5% |
| RAPP | $1.45B | -10.6 | · | · | -29.8% | · |
| PAHC | · | 12.9 | 17.1% | 6.6% | 29.7% | 33.8% |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | · |
| INVA | · | 6.1 | 14.7% | · | · | · |
| MAZE | $2.04B | -13.6 | · | · | -598.9% | · |
| XERS | $1.30B | · | 43.7% | 0.19% | -19.7% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 3, 2026